Explores enantioselective aldol reactions in α-ketoamides, suggesting new synthetic pathways.
Both α-ketoamides and γ-hydroxy-α-keto acids are biologically relevant structural motifs and valuable intermediates in the synthesis of biologically active molecules and natural products. Although considerable efforts have been devoted to developing efficient pyruvate-based aldol reactions, the most straightforward route to γ-hydroxy-α-ketoacids, the direct use of pyruvates is hampered by their intrinsic instability and high reactivity toward self-condensation and lactonization of the resulting aldols. As a result, such reactions remain limited to a narrow range of substituted pyruvate donors and highly electrophilic aldehyde acceptors. Here, we report a Cu(I)-catalyzed enantioselective aldol reaction, employing α-ketoamides as the practical alternative to pyruvates. This methodology provides efficient access to γ-hydroxy-α-ketoamides with very good enantioselectivity and good diastereoselectivity across a broad range of donors and aldehyde partners, including both enolizable and non-enolizable substrates. Beyond direct access to γ-hydroxy-α-ketoamides, the aldol adducts can be straightforwardly converted into isotetronic acids and other synthetically valuable compounds such as α,γ-dihydroxy carboxamides, amido and amino diols, and γ-butyrolactones. Moreover, by enabling direct use of amino-acid- and peptide-derived α-ketoamides, this platform provides streamlined access to peptide-functionalized ketoamide scaffolds of potential biological interest. This capability is further exemplified by a concise synthesis of (+)-Conagenin, a low-molecular-weight immunomodulator, which is efficiently assembled from an amino-acid-derived α-ketoamide precursor. Finally, combined kinetic and DFT studies elucidate the origin of stereocontrol and the distinct pathways operating for different substitution patterns of the α-ketoamide: N,N-disubstituted substrates react via a classical inner-sphere transition state, whereas N-monosubstituted analogs proceed through an unusual outer-sphere transition state involving a 10-electron rearrangement and formation of an iminolate intermediate.
No takes yet. Share an insight, caveat, or question.
Rodriguez-Urretavizcaya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: